Morgan Stanley’s Walgreens Boots Alliance WBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,184,041
Closed -$140M 8393
2025
Q2
$140M Sell
12,184,041
-4,058,813
-25% -$45.2M 0.01% 1099
2025
Q1
$181M Buy
16,242,854
+1,560,346
+11% +$16.9M 0.01% 900
2024
Q4
$137M Buy
14,682,508
+511,004
+4% +$4.74M 0.01% 1040
2024
Q3
$127M Buy
14,171,504
+2,370,544
+20% +$24.4M 0.01% 1066
2024
Q2
$143M Sell
11,800,960
-800,410
-6% -$13.6M 0.01% 959
2024
Q1
$273M Sell
12,601,370
-21,312,630
-63% -$474M 0.02% 659
2023
Q4
$885M Buy
33,914,000
+21,329,629
+169% +$477M 0.04% 443
2023
Q3
$280M Buy
12,584,371
+1,720,228
+16% +$45.7M 0.03% 575
2023
Q2
$310M Sell
10,864,143
-827,857
-7% -$27M 0.03% 550
2023
Q1
$404M Sell
11,692,000
-282,220
-2% -$10M 0.04% 423
2022
Q4
$447M Buy
11,974,220
+1,155,331
+11% +$43.4M 0.05% 369
2022
Q3
$340M Buy
10,818,889
+308,042
+3% +$11.4M 0.05% 398
2022
Q2
$398M Buy
10,510,847
+3,795,401
+57% +$163M 0.05% 354
2022
Q1
$301M Buy
6,715,446
+94,261
+1% +$4.64M 0.04% 405
2021
Q4
$345M Buy
6,621,185
+180,667
+3% +$8.75M 0.04% 386
2021
Q3
$303M Buy
6,440,518
+724,621
+13% +$34.9M 0.04% 396
2021
Q2
$301M Buy
5,715,897
+328,328
+6% +$17.7M 0.04% 404
2021
Q1
$296M Sell
5,387,569
-1,918,040
-26% -$94.8M 0.04% 363
2020
Q4
$291M Sell
7,305,609
-154,647
-2% -$5.99M 0.05% 361
2020
Q3
$268M Buy
7,460,256
+691,989
+10% +$27.1M 0.05% 311
2020
Q2
$287M Buy
6,768,267
+1,569,701
+30% +$66.7M 0.06% 267
2020
Q1
$238M Buy
5,198,566
+366,197
+8% +$18.6M 0.06% 267
2019
Q4
$285M Buy
4,832,369
+380,758
+9% +$21.9M 0.07% 285
2019
Q3
$246M Sell
4,451,611
-461,419
-9% -$24.7M 0.07% 297
2019
Q2
$269M Buy
4,913,030
+1,304,949
+36% +$69.4M 0.07% 275
2019
Q1
$228M Sell
3,608,081
-4,030,245
-53% -$275M 0.06% 299
2018
Q4
$522M Buy
7,638,326
+1,389,359
+22% +$108M 0.16% 141
2018
Q3
$456M Buy
6,248,967
+2,077,270
+50% +$141M 0.11% 184
2018
Q2
$250M Buy
4,171,697
+552,043
+15% +$35.5M 0.07% 285
2018
Q1
$237M Sell
3,619,654
-867,405
-19% -$62M 0.07% 289
2017
Q4
$326M Sell
4,487,059
-2,540,372
-36% -$179M 0.09% 239
2017
Q3
$543M Buy
7,027,431
+720,066
+11% +$57.7M 0.16% 138
2017
Q2
$494M Sell
6,307,365
-1,193,552
-16% -$98.2M 0.15% 159
2017
Q1
$623M Buy
7,500,917
+637,826
+9% +$53.5M 0.19% 113
2016
Q4
$568M Buy
6,863,091
+870,506
+15% +$72M 0.19% 115
2016
Q3
$483M Buy
5,992,585
+529,523
+10% +$43.2M 0.17% 133
2016
Q2
$455M Sell
5,463,062
-2,596,678
-32% -$210M 0.16% 140
2016
Q1
$679M Sell
8,059,740
-3,152,986
-28% -$252M 0.26% 79
2015
Q4
$955M Buy
11,212,726
+2,920,736
+35% +$248M 0.35% 46
2015
Q3
$689M Sell
8,291,990
-907,621
-10% -$82.1M 0.25% 81
2015
Q2
$777M Buy
9,199,611
+1,648,514
+22% +$142M 0.27% 71
2015
Q1
$639M Buy
7,551,097
+74,377
+1% +$5.92M 0.24% 94
2014
Q4
$570M Buy
7,476,720
+1,907,145
+34% +$127M 0.21% 108
2014
Q3
$330M Buy
5,569,575
+126,660
+2% +$8.31M 0.13% 189
2014
Q2
$403M Buy
5,442,915
+832,545
+18% +$58.2M 0.16% 152
2014
Q1
$304M Buy
4,610,370
+895,504
+24% +$56.3M 0.13% 194
2013
Q4
$213M Sell
3,714,866
-450,177
-11% -$26.2M 0.09% 249
2013
Q3
$224M Buy
4,165,043
+937,210
+29% +$47.1M 0.11% 214
2013
Q2
$143M Buy
+3,227,833
New +$157M 0.07% 309

Other funds holding WBA

Morgan Stanley's WBA Position: Q3 2025 in Review

Morgan Stanley sold out of Walgreens Boots Alliance (WBA) in Q3 2025, closing a stake of 12,184,041 shares — an estimated $140M sold.

Morgan Stanley first reported a position in WBA in Q2 2013 and held it in 49 quarters. The position peaked at $955M in Q4 2015. 9 funds tracked by Wall St. Rank hold WBA as of Q3 2025.

  • Morgan Stanley reported no remaining Walgreens Boots Alliance position as of Q3 2025 after selling out during the quarter.
  • Morgan Stanley sold 12,184,041 Walgreens Boots Alliance shares in Q3 2025, an estimated $140M.
  • Morgan Stanley first reported a position in Walgreens Boots Alliance in Q2 2013 and held it in 49 quarters.
  • Morgan Stanley's Walgreens Boots Alliance position peaked at $955M in Q4 2015.
  • 9 funds tracked by Wall St. Rank held Walgreens Boots Alliance as of Q3 2025.

Based on Morgan Stanley's 13F filing for Q3 2025, filed 14 Nov 2025.